SmithKline Beecham consumer health care profit margins nearing 20% goal -- Leschley.
This article was originally published in The Tan Sheet
Executive Summary
SMITHKLINE CONSUMER HEALTH CARE PROFIT MARGINS NEARING 20% GOAL, SmithKline Beecham CEO Jan Leschley noted at an April 16 "New Ventures in Health Care" conference at the Wharton School. The company's trading profit margin for the consumer health care sector was 16.7% in 1997, up .9% from the year before. While "it is not the [27%] margin that you have" in the pharmaceutical sector, Leschley acknowledged, it is "getting closer and closer to 20%, which is our goal."